NCT06336265View on ClinicalTrials.gov

Diaphragmatic Ultrasound to Predict the Therapeutic Effect of High-flow Nasal Cannula Oxygen Therapy

Not yet recruitingOBSERVATIONAL

Enrollment

269

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Hypoxic Respiratory Failure

Interventions

DIAGNOSTIC_TEST

Diaphragm ultrasound

Respiratory parameters, diaphragmatic activity, and variation rate of diaphragmatic thickness were recorded at the beginning of high-flow nasal cannula oxygen therapy, 1 hour after treatment, 3 hours after treatment, 6 hours after treatment, 9 hours after treatment, and 12 hours after treatment.

All Listed Sponsors

lead

Xingui Dai

OTHER

NCT06336265 - Diaphragmatic Ultrasound to Predict the Therapeutic Effect of High-flow Nasal Cannula Oxygen Therapy | Biotech Hunter | Biotech Hunter